Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two-step vs 2-hour infusion of imipenem/cilastatin in sepsis
NCT02616354Phase 4Unknown
- Sponsor
- Southeast University
- Start
- Jan 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of imipenem + cilastatin in sepsis, sponsored by Southeast University. Primary endpoint: Area under the plasma concentration versus time curve at 9 months. Status: unknown.
02
Drugs
imipenem + cilastatin
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT02616354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02616354.